ADC Therapeutics SA (ADCT)

ADC Therapeutics Revenue

ADC Therapeutics had revenue of $23.03M in the quarter ending March 31, 2025, with 27.59% growth. This brings the company's revenue in the last twelve months to $75.82M, up 10.49% year-over-year. In the year 2024, ADC Therapeutics had annual revenue of $70.84M with 1.84% growth.

• Revenue (ttm): $75.82M
• Revenue Growth: +10.49%
• P/S Ratio: 1.81
• Revenue / Employee: $286,102
• Employees: 265
• Market Cap: 179.02M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	70.84M	1.28M	1.84%
Dec 31, 2023	69.56M	-140.35M	-66.86%
Dec 31, 2022	209.91M	175.99M	518.89%
Dec 31, 2021	33.92M	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.